Search results
Why breast cancer recurrence rates are higher in Black women
Rolling Out· 5 days agoBreast cancer is a pervasive health concern that affects women globally, but its impact varies...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 15 hours agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Edgewood Oncology treats first two subjects in breast cancer trial
Clinical Trials Arena via Yahoo Finance· 3 days agoThe multicentre, open-label, nonrandomised, multiple dose study is designed...resistance to these...
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...
Nature· 4 days agoCancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical ...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 2 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 1 day agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical ..
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 19 hours ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression ...
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
Medscape· 4 days agoADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.
Nuclear receptors — studying genes to understand hormones - Nature Reviews Genetics
Nature· 3 days agoLigand-bound receptors undergo conformational changes to facilitate binding both to DNA and to co-factors that facilitate interactions with chromatin and core transcriptional ...
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and...
FOX 59 Indianapolis· 17 hours agoLunit will present detailed findings on several innovative studies, including the identification of HER2 ultra-low expression in breast cancer using AI-based ...